Loureirin A

Research use only not for human use.

Loureirin A has an inhibitory effect on platelet activation perhaps through an impairment of PI3K/Akt signaling.Loureirin A negatively affects agonist-induced platelet aggregation such as collagen collagen-related peptide (CRP) ADP and thrombin.

Loureirin A has an inhibitory effect on platelet activation perhaps through an impairment of PI3K/Akt signaling.Loureirin A negatively affects agonist-induced platelet aggregation such as collagen collagen-related peptide (CRP) ADP and thrombin. Loureirin A activates Wnt/-catenin pathway and promotes hair follicle stem cells (FSCs)-seeded tissue-engineered skin to repair skin wound.The molecular mechanism of Loureirin A and Wnt signaling pathway mediated anti- hepatic fibrosis and anti- angiogenesis may involve down- regulation the expression of Frizzled- 4inhibiting the synthesis and secretion of α- SMATGF- β1and the proliferation of HSCs.

——

PI3K/Akt/mTOR signaling

PI3K

PI3K

——

——

119425-89-7

286.32

C17H18O4

>98% (HPLC)

DMSO: ≥ 86.6 mg/mL (302.46 mM)

COc1ccc(CCC(=O)c2ccc(O)cc2)c(OC)c1

——

(-20℃)

With Ice Pack

≥ 2 years